-
Sherilyn Smith Encourages Women to Embrace Scars as Symbols of Resilience
-
Korea's Severe Asthma Patients Blocked from Biologics by Restrictive Reimbursement Rules
-
Belgium Signs Contract for 20 Rheinmetall Skyranger Air Defence Systems
-
Shanghai Science and Technology Museum Signs Pacts With London and Ottawa Institutions at CIIE
-
Spectrocell Strengthens Product Discovery and Customer Engagement with Bioz Badges
-
Fulcrum Metals PLC Announces Fulcrum to Increase Shareholding in Loyalist
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 10
-
New Gold IRA Investing Guide Explains How to Buy Gold in an IRA for American Consumers
-
RBI Data Reveals Divergence in Credit Card Spending and Debit Card Cash Withdrawals
-
First-time boat buyers advised to assess full ownership costs
-
Panthers expected to begin 2027 NRL season away from new stadium
-
Planning and preparation can reduce stress of interstate relocation
-
Sweet As app launches restaurant discovery platform
-
Two more arrested in Carrie Mullane suspected murder investigation
-
Phoenix Restaurants Offer Thanksgiving Dinner to Go for Pickup
-
MLA seeks inquiry into reported sectarian gestures on Ormeau Road
-
Mayo school appeals for information after convent and chapel vandalism
-
Louise O’Reilly attacks Simon Harris over unemployment remarks
-
Virginia overwhelms Arkansas 91-72 behind balanced scoring
-
Canadian soldier Aidan Goulding remembered at Vancouver funeral
-
Second major storm brings destructive winds and outages to British Columbia
-
Tayyab Arif hits 57 on Pakistan Test debut against Sri Lanka
-
Godzilla Minus Zero leads North American box office with $31.6m
-
Robert Trujillo discusses literacy and social justice children’s books
-
Advocate calls for coordinated support for children facing trafficking
-
Civil rights advocate William Bill Tucker dies aged 98
-
Medicare Open Enrollment Ends Dec. 7: Review Your Coverage Options
-
Pennsylvania Democrats secure state trifecta in midterm elections
-
US Treasury order targets bank transfers linked to crypto exchange MEXC
-
Godzilla Minus Zero sets foreign-language box-office opening record
-
Nvidia CEO Controversy Sparks Fears of Tighter U.S. AI Chip Curbs for Samsung and SK hynix
-
Eagles record six sacks as rushing attack struggles against Giants
-
Villeneuve teases James Bond casting at Los Angeles museum gala
-
Thames Water seeks to delay £12bn in debt repayments
-
Nottinghamshire launches specialist rural crime policing team
-
Newark boxing gym expands alternative education programme
-
China confirms talks over possible Xi-Putin-Trump summit
-
Democrats consider impeachment drive against Defence Secretary Hegseth
-
Rail journey offers a slower route to a Berlin city break
-
Energy bill plan could use HMRC income data to target support
-
Arsenal control title race as Manchester United fall into bottom three
-
Business owner earning £6,000 a month tackles £70,000 debt
-
Suspected Krakow gunman dies after attack that killed six
-
Nvidia chief faces inquiry after disclosing affair with suspected Chinese agent
-
Carrick backs Dalot after hostile reception from Manchester United fans
-
Comet returns as online electrical marketplace 14 years after collapse
Featured
Last news
DEA Blocks MMJ FDA Cannabis Research While Tribal Marijuana Transit Networks Operate in N.C. Unchecked
Watch the Senate hearing: https://dai.ly/x9j0le4Despite MMJ's full regulatory compliance and orphan drug status from the FDA, its DEA manufacturing registration (GROW MARIJUANA) remains stonewalled inside a DEA administrative court system now deemed unconstitutional under Axon and Jarkesy. Meanwhile, tribal transit networks face virtually no enforcement-exposing a hypocritical and dangerous DEA double standard.
BioNxt Launches Feasibility Study for Semaglutide Oral Thin Film as Alternative to Injection/Tablets
VANCOUVER, BC / ACCESS Newswire / June 23, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC:BNXTF)(FSE:BXT), is pleased to announce the launch of a feasibility study for the development of an oral dissolvable film (ODF) formulation of Semaglutide, a GLP-1 receptor agonist currently marketed globally under the brand names Ozempic®, Rybelsus®, and Wegovy®.
Xebra Announces Delay in Filing Financial Statements
VANCOUVER, BC / ACCESS Newswire / June 23, 2025 / Xebra Brands Ltd. ("Xebra") (XBRA:CSE)(XBRAF:OTCQB)(9YC:FSE), announces today that it was not in a position to file its audited annual financial statements, management's discussion and analysis and related officer certifications for the fiscal year ended February 28, 2025 (collectively the "Annual Filings") on or before the filing deadline of June 28, 2025, as required under applicable Canadian securities laws.
Blood, destruction at Damascus church after suicide attack
At the blood-stained Saint Elias church in Damascus, Umm George wept as she desperately searched for her son, who was among the worshippers when a suicide bomber struck on Sunday.
Muslim countries urge end to Israel's 'aggression' against Iran
Foreign ministers from countries of the Organisation of Islamic Cooperation (OIC) on Sunday urged Israel to end its "aggression" towards Iran, without mentioning the US strikes on the Islamic republic's nuclear sites.
Freed Belarus opposition figure urges Trump to help release all prisoners
Belarus opposition figure Sergei Tikhanovsky, who was released following an appeal from the White House, said Sunday that US President Donald Trump could secure the freedom of all Belarusian political prisoners.
Wave of syringe attacks mar France's street music festival
French police have detained twelve suspects after 145 people reported being pricked with syringes during the country's annual street music festival, officials said Sunday.
DEA Judge Mulrooney’s MMJ Marijuana Ruling May Be DEA’s Last Stand Before the Constitution Strikes Back
Judge Mulrooney's decision may have handed MMJ BioPharma Cultivation a defeat inside the DEA's walls, but in doing so, he may have handed MMJ a powerful victory in federal court. The record of constitutional violations and DEA violations is now preserved - the "Axon-Jarkesy defense"is primed - and the very administrative law judge system the DEA clings to may not survive scrutiny.
Eight dead in Brazil hot air balloon accident
At least eight people were killed Saturday when a hot air balloon with 21 passengers caught fire in southern Brazil, said the governor of Santa Catarina state, where the incident occurred.
Mexico's Sheinbaum claims drop in homicides, experts dubious
Mexican President Claudia Sheinbaum has claimed a sharp drop in homicides in the first eight months of her term, but analysts wonder whether the figures are trustworthy and, if so, can keep coming down.
Staff shortages bite as Greeks shun low-paid tourism jobs
Greek tourism student Katerina quit within a month of starting work at a five-star hotel in Halkidiki, one of the country's top destinations, because she said conditions were so dire.
Dutch footballer Promes extradited over cocaine smuggling case
Former Ajax and Dutch international footballer Quincy Promes has been extradited from Dubai to the Netherlands, prosecutors said Friday, after a conviction for smuggling more than a tonne of cocaine.
Second woman accuses French senator of drugging her
A French senator accused of drugging an MP with the intent to assault her is facing an accusation from another woman, according to French television.
More microplastics in glass bottles than plastic: study
Drinks including water, soda, beer and wine sold in glass bottles contain more microplastics than those in plastic bottles, according to a surprising study released by France's food safety agency Friday.
Two dead in Mexico as Hurricane Erick moves on from Mexican coast
Hurricane Erick killed at least two people as it swept through southern Mexico causing significant damage to coastal communities before weakening to a low-pressure system Thursday night, authorities said.
US appeals court allows Trump control of National Guard in LA
A US appeals court on Thursday ruled that President Donald Trump could continue control of National Guard troops in Los Angeles, over the objections of California Governor Gavin Newsom.
Cheap alms bowls imports hit Sri Lanka makers, monks
The alms bowl is a symbol of monks, yet in Sri Lanka artisans are struggling as cheap substitutes flood the market, igniting a debate over Buddhist tradition and quality.
US singer Chris Brown in London court on assault case
American R&B singer Chris Brown, the former boyfriend of superstar Rihanna, was due to appear in court Friday in London on assault charges.
Critic of Nicaragua's Ortega shot dead in exile in Costa Rica
A retired Nicaraguan army officer in exile who fiercely criticized authoritarian President Daniel Ortega was shot dead Thursday in neighboring Costa Rica, his family and officials said.
Envela to Participate in iAccess Alpha Virtual Best Ideas Summer Investment Conference 2025
IRVING, TX / ACCESS Newswire / June 20, 2025 / Envela Corporation today announced that its management team will be participating in the iAccess Alpha Virtual Best Ideas Summer Investment Conference 2025 on June 24-25, 2025. CEO John Loftus and CFO John DeLuca will deliver a company presentation at 3:30 PM ET on June 24th, followed by one-on-one meetings with investors on June 25th.
Inka Health Co-Founders Publish New Study Advancing Real-World Applicability of Lung Cancer Clinical Trial Outcomes
VANCOUVER, BC / ACCESS Newswire / June 20, 2025 / Onco-Innovations Limited(CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H,WKN:A3EKSZ) ("Onco" or the "Company") is pleased to announce that the Co-Founders of its wholly-owned subsidiary, Inka Health Corp. ("Inka Health"), have authored a significant new study titled Global Transportability of Clinical Trial Outcomes to Real-World Lung Cancer Populations: A Case Study using Lung-MAP S1400I1 (the "Study"), published in medRxiv in June 2025. The Study examines a key challenge in global cancer research by exploring how clinical trial results can be made more applicable to the diverse patient populations treated in routine clinical practice across different countries and healthcare systems. In this case, the approach demonstrated strong predictive performance, matching real-world outcomes within less than one percent over a 30-month period.2
Action Behavior Centers Hosts Community Impact Event with Special Olympics During ABCaba Clinical Conference
AUSTIN, TX / ACCESS Newswire / June 20, 2025 / Action Behavior Centers, a leading provider of compassionate applied behavior analysis (ABA) therapy for children with autism, hosted its inaugural ABCaba Clinical Conference on June 13 and 14 in Austin, Texas. Held in collaboration with the Global Autism Project, ABCaba brought together hundreds of ABA clinicians for two days of clinical innovation, continuing education, and advocacy focused on improving global access to quality autism care.
New to The Street Show #673 Airs Nationwide on Bloomberg TV - Saturday, June 21 at 6:30 PM EST Featuring FLOKI, NRX Pharmaceuticals (NASDAQ:NRXP), MUSQ - The Music ETF (NYSE:MUSQ), Health In Tech (NASDAQ:HIT), and Vita Bella
The show is sponsored by The Sustainable Green Team's (OTC:SGTM) Waterless Garden
Wall Street to Wildlife: New Children's Book Aims to Save Endangered Species, One Page at a Time
NEW YORK CITY, NY / ACCESS Newswire / June 20, 2025 / When most people retire, they take up hobbies, travel the world, or slow down to enjoy a quieter life. Carole Couture did the opposite. After three decades as a financial advisor navigating boardrooms and balance sheets, Couture has re-emerged with a mission that couldn't be further from spreadsheets-protecting endangered species and igniting young minds through literature. Her debut children's book, The Adventures of Pablo the Pangolin, is more than an illustrated tale-it's a clarion call against illegal wildlife trafficking and a celebration of empathy, courage, and ecological responsibility.
Ditchit Detonates Iconic Twitter Bird to Symbolize Launch of Local Marketplace
DOVER, DE / ACCESS Newswire / June 20, 2025 / In a fiery spectacle worthy of Silicon Valley lore, Ditchit - a rising star in the online marketplace space and rival to OfferUp - has made headlines by purchasing and then blowing up the original 560-pound Twitter bird sign once perched atop the company's San Francisco headquarters.
Dr. John Peloza to Join Keynote Panel at Becker's 22nd Annual Spine, Orthopedic and Pain Management-Driven ASC Conference
CHICAGO, IL / ACCESS Newswire / June 20, 2025 / Dr. John Peloza, internationally recognized spine surgeon and innovator in spinal motion preservation, will join the keynote panel "Cervical Arthroplasty-Two Decades of Evolution and the Road Ahead" at the 22nd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, hosted by Becker's Healthcare. The session will take place June 21, 2025, at the Swissotel Chicago, bringing together the field's leading voices to discuss two decades of advancement in artificial disc replacement and the future trajectory of cervical arthroplasty.
Aptevo Therapeutics Announces Closing of $8 Million Offering Priced At-the-Market Under Nasdaq Rules
SEATTLE, WASHINGTON / ACCESS Newswire / June 20, 2025 / Aptevo Therapeutics Inc. (Nasdaq:APVO), a clinical-stage biotechnology company focused on developing novel immune-oncology therapeutics based on its proprietary ADAPTIR™ and ADAPTIR-FLEX™ platform technologies, today announced the closing of its previously announced offering of (i) 2,465,000 shares of its common stock or pre-funded warrants in lieu thereof and (ii) warrants to purchase up to an aggregate of 12,325,000 shares of its common stock (the "Common Warrants") at a purchase price of $3.25 per share and associated Common Warrants in a registered direct offering priced at-the-market under Nasdaq rules. Each share of common stock is being offered together with five Common Warrants, each to purchase one share of common stock. The Common Warrants have an exercise price of $3.25 per share, are exercisable upon stockholder approval, and will expire five years following the date stockholder approval.
KLAS Research, St. Luke's Health System, and Ambience Healthcare Unveil Groundbreaking Impact Study on Ambient AI
Independent report confirms Ambience Healthcare's AI platform reduces clinician burnout, enhances patient care, and strengthens financial and compliance outcomes
Aptevo Expands Differentiated CD3 Portfolio with APVO455, Advancing a Suite of Targeted T-cell Engagers
Mipletamig-driven clinical validation of the CRIS-7 derived CD3-binding domain underpins Aptevo's expansion from hematologic to solid tumorsNew candidate APVO455 targets Nectin-4+ cancers, joins mipletamig (AML) and APVO442 (prostate) in Aptevo's tumor-directed CD3 suite
Brenmiller Energy Appoints Boaz Toshav to Serve as an Independent Director on the Board
Experienced Global Investment Executive and Strategic Advisor to Support the Company's Next Phase of Growth
Organto Foods Announces Final Settlement of Convertible Debenture Obligations
VANCOUVER, BC / ACCESS Newswire / June 20, 2025 / Organto Foods Inc. (TSXV:OGO)(OTC PINK:OGOFF) ("Organto" or the "Company") is pleased to announce that, as part of its efforts to reduce debt and increase equity in the Company, it has completed the previously announced settlement (the "Settlement") of its 8.0% convertible unsecured subordinated debentures due November 30, 2026 with an aggregate face value of C$8,050,000 (the "Debentures") (see the Company's news releases dated May 1, 2025, March 30, 2025, and March 11, 2025).
Relief Therapeutics Receives FDA Response to QIDP Request for RLF-TD011
GENEVA, SWITZERLAND / ACCESS Newswire / June 20, 2025 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY ) (Relief or the Company), a biopharmaceutical company committed to delivering innovative treatment options for select specialty, unmet and rare diseases, today announced that its initial request for Qualified Infectious Disease Product (QIDP) designation for RLF-TD011 for the treatment of epidermolysis bullosa (EB) was not granted by the U.S. Food and Drug Administration (FDA). The FDA determined that the investigational therapy does not currently meet the criteria for QIDP designation.